Hepp, Nicola http://orcid.org/0000-0003-4571-0439
Frederiksen, Anja Lisbeth http://orcid.org/0000-0002-7944-8910
Duno, Morten http://orcid.org/0000-0002-8436-7744
Jørgensen, Niklas Rye http://orcid.org/0000-0001-9624-5210
Jensen, Jens-Erik Beck http://orcid.org/0000-0003-4290-0480
Funding for this research was provided by:
The A.P. Møller Foundation for the Advancement of Medical Science (Journalnr. 17-L-0254)
Danish Osteoporosis Association (-)
Article History
Received: 6 January 2022
Accepted: 15 August 2022
First Online: 19 August 2022
Declarations
:
: AFL, MD and NRJ have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. NH has received research funding from Alexion, AstraZeneca Rare Disease and lecturer fees from Gedeon Richter and UCB. JEBJ is a board member in Eli Lilly, Amgen, Gedeon Richter and UCB, received funding from Eli Lilly and Amgen and consulting fees from UCB, Giliad and Amgen.